Endoplasmic reticulum (ER) News and Research

RSS

Watson third quarter net income increases 31% to $138.7 million

Watson Pharmaceuticals, Inc. today reported net revenue of $1.1 billion for the third quarter ended September 30, 2011, an increase of 23 percent when compared to $882.4 million in the third quarter 2010. On a non-GAAP basis, net income for the third quarter 2011 increased 31 percent to $138.7 million or $1.09 per diluted share, compared to $105.9 million or $0.85 per diluted share in the third quarter 2010.

1 Nov 2011

ER-positive breast cancer patients with high levels of heat shock factor 1 experience poor outcomes

Whitehead Institute scientists report that patients whose estrogen receptor (ER)-positive breast cancers have high levels of the ancient cellular survival factor heat shock factor 1 (HSF1) experience poor outcomes—including increased mortality.

1 Nov 2011

J&JPRD submits NUCYNTA ER sNDA to FDA for DPN associated neuropathic pain

Johnson & Johnson Pharmaceutical Research & Development, L.L.C. announced today that it has submitted a supplemental New Drug Application to the U.S. Food and Drug Administration for NUCYNTA ER (tapentadol) extended-release tablets, an oral analgesic, for the management of neuropathic pain associated with diabetic peripheral neuropathy in adults.

31 Oct 2011

Mylan receives final FDA approval for Morphine Sulfate ER Tablets ANDA

Mylan Inc. today announced that its subsidiary Mylan Pharmaceuticals Inc. has received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Morphine Sulfate Extended-release (ER) Tablets, 15 mg, 30 mg, 60 mg, 100 mg and 200 mg, the generic version of Purdue Pharma's MS Contin, an opioid analgesic for moderate to severe pain management.

27 Oct 2011

VA reviewing millions spent outside the agency on care in Phoenix

The Arizona Republic reports that the Veterans Administration is looking into spending after noting that the system had surpassed its budget for community fee care.

24 Oct 2011

CDC: Visits to emergency rooms on the rise

Visits to hospital emergency departments increased to an all-time high of 136 million in 2009, according to new estimates released by the Centers for Disease Control and Prevention.

19 Oct 2011

Christie introduces hand-held version of VeinViewer

Christie Medical Holdings, Inc. today announced the market launch of the company's newest product, VeinViewer Flex. With the addition of this fifth-generation VeinViewer, following the recent launch of VeinViewer VisionXTND, Christie now provides a full portfolio of three product tiers that addresses the needs of every major health care market segment.

18 Oct 2011

Johnson & Johnson third quarter sales increase 6.8% to $16.0 billion

Johnson & Johnson today announced sales of $16.0 billion for the third quarter of 2011, an increase of 6.8% as compared to the third quarter of 2010. Operational results increased 2.6% and the positive impact of currency was 4.2%. Domestic sales declined 3.7%.

18 Oct 2011

Study identifies SIRT2 tumor suppressor protein linked to cancer

The list of aging-associated proteins known to be involved in cancer is growing longer, according to research by investigators at Vanderbilt-Ingram Cancer Center and the National Institutes of Health.

18 Oct 2011

Merck’s diabetes combo pill gets FDA nod

The U.S. Food and Drug Administration (FDA) has approved Merck & Co.’s Juvisync diabetes drug, a combination pill for type 2 diabetes. Juvisync combines two Merck drugs already on the market, 1) glucose-lowering Januvia (Sitagliptin) medication and 2) cholesterol-lowering Zocor (Simvastatin).

10 Oct 2011

Ibris to develop a quick and economical analysis of tissue from breast cancer biopsies

The National Institutes of Health (NIH) has awarded a Rutgers-affiliated company $207,000 to develop a quick and economical analysis of tissue from breast cancer biopsies. The technology is designed to predict how aggressive a common form of breast cancer is likely to be, helping physicians and patients plan effective therapies that minimize side effects.

7 Oct 2011

Longer looks: A new life for Bart Stupak; The Komen Foundation and BPA; moving primary care out of the ER

Former Democratic congressman Bart Stupak is relishing the good life. After nine terms in the House of Representatives, the once obscure, pro-life, conservative legislator who became the flash point in last year's historic health care debate gave up his seat to become a gilded Washington operative - a partner in the Government and Legislative Affairs Group of Venable LLP. … Even before he negotiated a last-minute deal with President Obama to ban federal funding for abortion and provided the defining vote, he called his life "a living hell." "I was the face of health care. Whatever you thought about it, I was it," he says calmly. "I'm surprised I never got shot."

7 Oct 2011

Federal officials extend Ariz. Medicaid program while reviewing new plan; Wis. announces eligibility changes to cut budget shortfall

In other state Medicaid news, doctors in Washington state are suing to stop a new rule that limits enrollees' visits to the emergency department and Gov. Cuomo's administration dismisses a proposal for N.Y. to pay for transgender surgery.

4 Oct 2011

Hospital execs, other 'local' VIPs tend to get fast care in ER

In a country where the average emergency room wait now tops four hours, it's a rare American patient who doesn't wonder whether a hefty hospital donation or a family connection may be the secret to getting speedier care. Now, it turns out, the answer appears to be yes, at least according to a pair of small but telling surveys that conclude that being a VIP in the ER does come with certain perks.

3 Oct 2011

Hospitals confront budget strains, debt, market pressure

News outlets offer a variety of reports on how hospitals are faring in the health care marketplace. The outlook is full of challenges.

1 Oct 2011

First Edition: September 30, 2011

Today's headlines include reports about how new and old health policy positions are playing on the campaign trail.

30 Sep 2011

Calif. bill could affect out-patient surgery centers; some Florida public hospitals prosper

Also in news about local hospitals, the Mayo Clinic announces plans to develop a new medical school branch in Arizona and a Minn. hospital is accused of dumping a patient.

29 Sep 2011

Combination of Afinitor, exemestane reduces risk of breast cancer progression in women

A pivotal Phase III study shows Afinitor (everolimus) tablets plus exemestane, a hormonal therapy, more than doubled the time women lived without tumor growth (progression-free survival; PFS) and significantly reduced the risk of cancer progression by 57% versus exemestane alone in patients with advanced breast cancer.

26 Sep 2011

Rotavirus vaccine saved 65,000 hospitalizations and $278 million in healthcare costs: Study

The latest research shows that since the 2006 introduction of routine inoculation against rotavirus -- a leading cause of diarrhea in infants and young children -- almost 65,000 fewer American children have been hospitalized and about $278 million in healthcare costs have been saved.

26 Sep 2011

Loyola offers 15 minute emergency balloon angioplasty for heart attack patients

When 45-year-old Bobbie Jeske arrived at Loyola's ER with a massive, life-threatening heart attack, it took Dr. Fred Leya just 15 minutes to perform an emergency balloon angioplasty.

21 Sep 2011

Endoplasmic reticulum (ER) News and Research

Watson third quarter net income increases 31% to $138.7 million

ER-positive breast cancer patients with high levels of heat shock factor 1 experience poor outcomes

J&JPRD submits NUCYNTA ER sNDA to FDA for DPN associated neuropathic pain

Mylan receives final FDA approval for Morphine Sulfate ER Tablets ANDA

VA reviewing millions spent outside the agency on care in Phoenix

CDC: Visits to emergency rooms on the rise

Christie introduces hand-held version of VeinViewer

Johnson & Johnson third quarter sales increase 6.8% to $16.0 billion

Study identifies SIRT2 tumor suppressor protein linked to cancer

Merck’s diabetes combo pill gets FDA nod

Ibris to develop a quick and economical analysis of tissue from breast cancer biopsies

Longer looks: A new life for Bart Stupak; The Komen Foundation and BPA; moving primary care out of the ER

Federal officials extend Ariz. Medicaid program while reviewing new plan; Wis. announces eligibility changes to cut budget shortfall

Hospital execs, other 'local' VIPs tend to get fast care in ER

Hospitals confront budget strains, debt, market pressure

First Edition: September 30, 2011

Calif. bill could affect out-patient surgery centers; some Florida public hospitals prosper

Combination of Afinitor, exemestane reduces risk of breast cancer progression in women

Rotavirus vaccine saved 65,000 hospitalizations and $278 million in healthcare costs: Study

Loyola offers 15 minute emergency balloon angioplasty for heart attack patients

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News